Neuraxis, Inc.
NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. The company offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 8-21 years of age with functional abdominal pain associated with irritable bowel syndrome. It se… Read more
Neuraxis, Inc. (NRXS) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: -0.625x
Based on the latest financial reports, Neuraxis, Inc. (NRXS) has a cash flow conversion efficiency ratio of -0.625x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-1.43 Million) by net assets ($2.28 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Neuraxis, Inc. - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Neuraxis, Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Neuraxis, Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Neuraxis, Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cleo Diagnostics Ltd
AU:COV
|
-0.497x |
|
Acorn Energy, Inc. Common Stock
OTCQB:ACFN
|
0.124x |
|
Pollux Investasi Internasional Tbk PT
JK:POLI
|
0.013x |
|
Prakash Pipes Limited
NSE:PPL
|
0.022x |
|
Kumho Electric
KO:001210
|
0.123x |
|
LINMON MEDIA LTD -000025
F:8MN
|
N/A |
|
Panache Digilife Limited
NSE:PANACHE
|
0.050x |
|
Cisadane Sawit Raya Pt
JK:CSRA
|
0.085x |
Annual Cash Flow Conversion Efficiency for Neuraxis, Inc. (2020–2024)
The table below shows the annual cash flow conversion efficiency of Neuraxis, Inc. from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $2.07 Million | $-6.10 Million | -2.949x | -161.82% |
| 2023-12-31 | $-1.40 Million | $-6.69 Million | 4.770x | +1057.01% |
| 2022-12-31 | $-5.57 Million | $-2.30 Million | 0.412x | -84.76% |
| 2021-12-31 | $-825.66K | $-2.23 Million | 2.706x | +207.46% |
| 2020-12-31 | $1.64 Million | $-4.14 Million | -2.518x | -- |